date:Apr 22, 2013
s infant milk formula brands in South Africa would be licensed to a third party for ten years.
Nestl is divesting assets following its $11.9bn acquisition of Pfizer's infant nutrition business, in order to comply with antitrust regulators.
Aspen is acquiring Pfizer's product lines from Nestl as part of its efforts to strengthen its presence in Australia, Latin America and sub-Saharan Africa.
Aspen chief executive officer Stephen Saad said the transactions support Aspen's ambitions to extend i